Delivery to the lower respiratory tract is required for effective immunization with Newcastle disease virus-vectored vaccines intended for humans
about
Newcastle disease virus-vectored vaccines expressing the hemagglutinin or neuraminidase protein of H5N1 highly pathogenic avian influenza virus protect against virus challenge in monkeys.Evaluation of the replication, pathogenicity, and immunogenicity of avian paramyxovirus (APMV) serotypes 2, 3, 4, 5, 7, and 9 in rhesus macaquesA host-restricted viral vector for antigen-specific immunization against Lyme disease pathogen.Newcastle disease virus-vectored rabies vaccine is safe, highly immunogenic, and provides long-lasting protection in dogs and catsNewcastle disease virus expressing human immunodeficiency virus type 1 envelope glycoprotein induces strong mucosal and serum antibody responses in Guinea pigsAvian paramyxovirus serotype-1: a review of disease distribution, clinical symptoms, and laboratory diagnosticsImmunization of cattle with recombinant Newcastle disease virus expressing bovine herpesvirus-1 (BHV-1) glycoprotein D induces mucosal and serum antibody responses and provides partial protection against BHV-1.Respiratory tract immunization of non-human primates with a Newcastle disease virus-vectored vaccine candidate against Ebola virus elicits a neutralizing antibody responseModified Newcastle disease virus vectors expressing the H5 hemagglutinin induce enhanced protection against highly pathogenic H5N1 avian influenza virus in chickensThe interferon antagonistic activities of the V proteins from two strains of Newcastle disease virus correlate with their known virulence properties.Opportunities and challenges of the pulmonary route for vaccination.Recent developments with live-attenuated recombinant paramyxovirus vaccines.RNA-based viral vectors.Recombinant Newcastle disease virus-vectored vaccines against human and animal infectious diseases.Intravenously injected Newcastle disease virus in non-human primates is safe to use for oncolytic virotherapy.Chimeric rabies glycoprotein with a transmembrane domain and cytoplasmic tail from Newcastle disease virus fusion protein incorporates into the Newcastle disease virion at reduced levelsAvian Paramyxovirus Type-3 as a Vaccine Vector: Identification of a Genome Location for High Level Expression of a Foreign Gene.Pigeon paramyxovirus type 1 from a fatal human case induces pneumonia in experimentally infected cynomolgus macaques (Macaca fascicularis).
P2860
Q30382650-7D568D88-CC25-4169-8E2C-4C839D0530FCQ35018292-DC764AE1-E6BC-4796-BEA8-0884A0BD122DQ35112976-9BB2A9CA-CD21-4786-85F7-1B4B0157AF22Q35140435-14617B83-A5AE-4BE4-A6B5-DDE13673CE10Q35275117-BCA799CD-FBCD-4615-BA1E-C741910E7D2CQ35936803-E5747B04-74C6-4E12-A98C-BDC00C241C70Q36190495-11825F6B-FB07-4176-A06E-79986955DEEDQ36190519-DA58AC52-A1F7-4907-8DBA-6CED51883095Q36692742-B7685E81-B666-498F-A75E-4AEEDE162B09Q37468199-F2C15647-596E-4B2A-B79B-1D23A9789557Q37857851-BDEE55D3-D7A2-4DDF-9B0D-41B793F98105Q38008607-A5B2FEB9-516B-4B75-AA7D-B0BEFC7377EBQ38266413-DEE94CB9-BD5C-473E-AC60-045F1FC21CFCQ38559266-46EAB714-933A-465D-9A47-4CCE836E4CD3Q38953230-F00356E7-265E-4824-856B-DB4FFF2A773EQ39498475-5FF0581C-E776-4BDD-AC55-AD31AE0C3086Q40214432-BF70F2D1-E9D9-4802-A905-5675E9EBAC2FQ47164675-5184D7F1-6252-4010-BDF8-C89B7C5CFACD
P2860
Delivery to the lower respiratory tract is required for effective immunization with Newcastle disease virus-vectored vaccines intended for humans
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 23 January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Delivery to the lower respirat ...... d vaccines intended for humans
@en
Delivery to the lower respirat ...... vaccines intended for humans.
@nl
type
label
Delivery to the lower respirat ...... d vaccines intended for humans
@en
Delivery to the lower respirat ...... vaccines intended for humans.
@nl
prefLabel
Delivery to the lower respirat ...... d vaccines intended for humans
@en
Delivery to the lower respirat ...... vaccines intended for humans.
@nl
P2093
P2860
P1433
P1476
Delivery to the lower respirat ...... d vaccines intended for humans
@en
P2093
Alexander Bukreyev
Brian R Murphy
Jerrold M Ward
Joshua M DiNapoli
Lijuan Yang
Lily Cheng
Peter L Collins
Siba K Samal
Subbiah Elankumaran
P2860
P304
P356
10.1016/J.VACCINE.2009.01.009
P407
P577
2009-01-23T00:00:00Z